Cyclobenzaprine Hydrochloride
Product Images NDC 50436-0846

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 50436-0846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 01)

Chemical structure of Cyclobenzaprine Hydrochloride, showing the three-ring system connected to a side chain with nitrogen and hydrochloride (HCl) components.*

FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 02)

A data table comparing the frequency of adverse effects including drowsiness, dry mouth, fatigue, and headache among subjects taking Cyclobenzaprine HCl Tablets at 5 mg and 10 mg doses versus placebo, with sample sizes of 464, 249, and 469 respectively.*

FDA Label Image

Image (7d5e3bad 7f85 4e2b 81c5 7981c456e45f 03)

A data table comparing the incidence percentages of side effects drowsiness, dry mouth, and dizziness during Clinical Studies and a Surveillance Program with Cyclobenzaprine Hydrochloride 10 mg tablets. The rates shown are 39% vs. 16% for drowsiness, 27% vs. 7% for dry mouth, and 11% vs. 3% for dizziness respectively.*

FDA Label Image

Label Image (Lbl504360846)

Cyclobenzaprine Hydrochloride 10 mg tablet label from Unit Dose Services, showing a 30 tablet count. The label includes lot number, expiration date placeholders, manufacturer information for Invagon Pharm, and storage instructions. The product is identified with NDC 50436-0846 and is marked for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.